Loading…

Oxidative stress in patients with coronavirus disease and end-stage renal disease: a pilot study

Oxidative stress, an imbalance between reactive oxygen species production and antioxidant capacity, increases in patients with coronavirus disease (COVID-19) or renal impairment. We investigated whether combined COVID-19 and end-stage renal disease (ESRD) would increase oxidative stress levels compa...

Full description

Saved in:
Bibliographic Details
Published in:BMC nephrology 2024-05, Vol.25 (1), p.155-155, Article 155
Main Authors: Beck, Nam-Seon, Seo, Yeonju, Park, Taesung, Jun, Sang-Sin, Im, Joung-Il, Hong, Sae-Yong
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Oxidative stress, an imbalance between reactive oxygen species production and antioxidant capacity, increases in patients with coronavirus disease (COVID-19) or renal impairment. We investigated whether combined COVID-19 and end-stage renal disease (ESRD) would increase oxidative stress levels compared to each disease alone. Oxidative stress was compared among three groups. Two groups comprised patients with COVID-19 referred to the hospital with or without renal impairment (COVID-ESRD group [n = 18]; COVID group [n = 17]). The third group (ESRD group [n = 18]) comprised patients without COVID-19 on maintenance hemodialysis at a hospital. The total oxidative stress in the COVID-ESRD group was lower than in the COVID group (p = 0.047). The total antioxidant status was higher in the COVID-ESRD group than in the ESRD (p 
ISSN:1471-2369
1471-2369
DOI:10.1186/s12882-024-03584-0